ORCA
Online Research @ CardiffÂ
Browse by All Cardiff Authors
![[up]](/style/images/multi_up.png)
Up a levelNumber of items: 2.
Beresford, Mark, Casbard, Angela  ORCID: https://orcid.org/0000-0001-6241-3052, Hudson, Zoe, Carucci, Margherita, Ingarfield, Kate, Gee, Julia ORCID: https://orcid.org/0000-0001-6483-2015, Smith, Joanna ORCID: https://orcid.org/0000-0003-4234-6686, Kitson, Terri ORCID: https://orcid.org/0000-0001-6333-046X, Alchami, Fouad, Madden, Tracie-Ann ORCID: https://orcid.org/0000-0001-7880-7873, Hayward, Larrie, Hwang, David, Spensley, Saiqa, Waters, Simon, Wheatley, Duncan and Jones, Robert H. ORCID: https://orcid.org/0000-0003-3576-9496
2023.
Fulvestrant plus vandetanib versus placebo for the treatment of patients with metastatic breast cancer resistant to aromatase inhibitor therapy (FURVA): a multicentre, Phase 2, randomised controlled trial.
BJC Reports
1
(1)
, 13.
10.1038/s44276-023-00016-8
|
|
|
Hudson, Zoe Ann
2021.
Investigation of biomarker determinants of treatment
efficacy of fulvestrant +/- the RET inhibitor vandetanib in
oestrogen receptor positive breast cancer.
PhD Thesis,
Cardiff University.
Item availability restricted. |
|
Cardiff University Information Services